Our selected publications (Last update :
21/08/09
)
- Retout S, Comets E, Samson A, Mentré F.
Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates.
Statistics in Medicine, 2007, 26, 5162- 5179. (Link to full text)
- Panhard X, Taburet AM, Piketti C, Mentré F.
Impact of modelling intra-subject variability on tests based on non-linear mixed-effects models in crossover PK trials with application to the interaction of tenofovir on atazanavir in HIV patients.
Statistics in Medicine, 2007, 26, 1268-1284. (Link to full text)
- Samson A, Lavielle M, Mentré F.
Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: Application to HIV dynamics model.
Computational Statistics and Data Analysis, 2006, 51, 1562-1574. (Link to full text)
- Brendel K, Comets E, Laffont C, Laveille C, Mentré F.
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide
Pharmaceutical Research, 2006, 23, 2036-2049. (Link to full text)
- Bazzoli C, Retout S, Mentré F.
Fisher information matrix for nonlinear mixed effects multiple response models: Evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
Statistics in Medicine, 2009.
Link to publication
- Gros PA*, Le Nagard H*, Tenaillon O
The evolution of epistasis and its links with genetic robustness, complexity and drift in a phenotypic model of adaptation.
Genetics, 2009, 182, 277–293.
* The two authors equally contributed to this work
Link to publication
- Panhard X, Samson A.
Extension of the SAEM algorithm for nonlinear mixed models with 2 levels of random effects.
Biostatistics, 2009, 10, 121-135.
Link to publication
- Bertrand J, Comets E, Mentré F.
Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters.
Journal of Biopharmaceutical Statistics , 2008, 18, 1084-1102.
Link to publication
- Duval X, Leport C.
Prophylaxis of infective endocarditis: current tendencies, continuing controversies.
The Lancet Infectious Diseases, 2008, 8, 225-232.